Vitamin E analogues as mitochondria‐targeting compounds: From the bench to the bedside?
- 23 December 2008
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 53 (1) , 129-139
Abstract
Despite considerable effort focusing on designing and finding efficient anti‐cancer drugs over the last decade, little progress has been achieved, in particular in case of highly recalcitrant malignancies. Also, since there is a trend suggesting that deaths from cancers may be more frequent than from cardiovascular diseases, it is important to look for novel efficient and selective therapeutic approaches to gradually start winning the battle with cancer. Redox‐silent vitamin E analogues, epitomised by α‐tocopheryl succinate, give some hope in the quest for drugs with such properties. Thus far, these agents have been successfully tested in experimental animals with different types of cancer, showing high efficacy against malignancies including HER2‐positive breast carcinomas or malignant mesotheliomas. Further research will provide additional, necessary data to launch clinical trials, possibly in near future, translating into development of innovative anti‐cancer drugs acting by targeting mitochondria selectively in cancer cells.Keywords
This publication has 93 references indexed in Scilit:
- α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex IIOncogene, 2008
- Mitochondrial Medicine: Pharmacological targeting of mitochondria in diseaseBritish Journal of Pharmacology, 2007
- Vitamin E Analogs, a Novel Group of “Mitocans,” as Anticancer Agents: The Importance of Being Redox-SilentMolecular Pharmacology, 2007
- A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 ExpressionCancer Research, 2007
- Molecular mechanism of ‘mitocan’‐induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl‐2 family proteinsFEBS Letters, 2006
- 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growthJournal of Cancer Research and Clinical Oncology, 2005
- α-Tocopheryl Succinate Inhibits Malignant Mesothelioma byDisrupting the Fibroblast Growth Factor Autocrine LoopJournal of Biological Chemistry, 2005
- Activation of PKC but Not of ERK Is Required for Vitamin E-Succinate-Induced Apoptosis of HL-60 CellsBiochemical and Biophysical Research Communications, 2001
- RRR‐α‐tocopheryl succinate inhibits el4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrestNutrition and Cancer, 1997
- RRR‐α‐tocopheryl succinate induces apoptosis in avian retrovirus‐transformed lymphoid cellsNutrition and Cancer, 1996